IBOGF (Universal Ibogaine) Total Liabilities: $2.67 Mil (As of Apr. 2025)


What is Universal Ibogaine Total Liabilities?

Universal Ibogaine IBOGF -1.07% Total Liabilities is $2.67 Mil as of Apr. 2025.

Universal Ibogaine's Total Liabilities for the quarter that ended in Apr. 2025 was $2.67 Mil.

Universal Ibogaine's quarterly Total Liabilities declined from Oct. 2024 ($2.50 Mil) to Jan. 2025 ($2.39 Mil) but then increased from Jan. 2025 ($2.39 Mil) to Apr. 2025 ($2.67 Mil).

Universal Ibogaine's annual Total Liabilities increased from Jul. 2022 ($1.84 Mil) to Jul. 2023 ($2.84 Mil) but then declined from Jul. 2023 ($2.84 Mil) to Jul. 2024 ($2.57 Mil).

Universal Ibogaine Total Liabilities Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Total Liabilities Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Total Liabilities
Get a 7-Day Free Trial 0.02 1.75 1.84 2.84 2.57

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 2.57 2.50 2.39 2.67

Universal Ibogaine Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Universal Ibogaine's Total Liabilities for the fiscal year that ended in Jul. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.728+(1.84+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.57

Total Liabilities=Total Assets (A: Jul. 2024 )-Total Equity (A: Jul. 2024 )
=3.291-0.723
=2.57

Universal Ibogaine's Total Liabilities for the quarter that ended in Apr. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.439+(1.232+-2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.67

Total Liabilities=Total Assets (Q: Apr. 2025 )-Total Equity (Q: Apr. 2025 )
=2.866-0.195
=2.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $2.67 Mil mean?
Universal Ibogaine (IBOGF) has a Total Liabilities of $2.67 Mil as of Apr. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Universal Ibogaine and its competitors.
Is Universal Ibogaine's Total Liabilities too high?
Universal Ibogaine's current Total Liabilities is $2.67 Mil.
How does Universal Ibogaine's Total Liabilities compare to LABT and CALC?
Universal Ibogaine's Total Liabilities of $2.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Universal Ibogaine and its competitors. Universal Ibogaine's current Total Liabilities is $2.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Total Liabilities of $2.67 Mil. The current Total Liabilities is $2.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Total Liabilities is $2.67 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.